BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith commences an investigation on behalf of Axovant Sciences Ltd. (“Axovant Sciences” or the “Company”) (NASDAQ: AXON) investors concerning the Company and its officers’ possible violations of federal securities laws.
On February 12, 2018, Axovant Sciences announced that Chief Executive Officer David Hung had resigned as CEO and from the Company’s board of directors. In addition the Company also announced that Marion McCourt, President and Chief Operating Officer had resigned, and Kate Falberg, Tony Vernon and Patrick Machado have resigned as members of the Company’s board of directors.
On this news, shares of Axovant Sciences dropped $0.41 or over 20%, to close at $1.50 on February 12, 2018, thereby injuring investors.
If you purchased Axovant Sciences securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.